Castration-Resistant Prostate Cancer
Castration-resistant prostate cancer (CRPC) is a form of prostate cancer that no longer responds to treatments that lower testosterone, leading to continued cancer growth and progression.
Castrate-Resistant Prostate Cancer: Acetylsalicylic Acid and Atorvastatin Study
We are investigating whether acetylsalicylic acid and atorvastatin can improve survival in patients with castrate-resistant prostate cancer. The study will also look at other health impacts and safety of these medications.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have prostate cancer that has not been treated with curative local therapy?
- Are you currently taking any medications that could interact with trial drugs, such as acetylsalicylic acid (Aspirin) or atorvastatin (Lipitor)?
- Have you had any serious medical conditions that could affect your ability to participate in this trial?
- Have you had any cancer other than non-melanoma skin cancer in the last 2 years?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Resitune
Tahor
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
CHU De Martinique
oncology
Amilly, France
Groupe Hospitalier Diaconesses Croix Saint Simon
oncology
Bagnolet, France
Hopital Tenon
oncology
Bagnolet, France
Sponsor: Institut Gustave Roussy
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.